Posted by Michael Wonder on 20 Sep 2023
CHMP adopts positive opinion to extend the use of Veklury (remdesivir) to treat COVID-19 in people with hepatic impairment
19 September 2023 - This positive opinion reinforces Veklury’s strong safety profile.
Gilead Sciences today announced that the CHMP of the EMA granted a positive opinion for the use of Veklury (remdesivir) to treat people with COVID-19 with mild to severe hepatic impairment.
